Ascendis

Quote






The worst of the worst. Selling a commodity with no clear path to getting it paid for. One of those paid on referral gigs where the dirty reps make a little money at first and either bolt or get caught.
 






What an earnings call today! The boys can dance around the question but the fact remains...nobody is paying for Skytrofa. The overwhelming majority of the 708 patients are on drug provided by Ascendis. That is why you missed the revenue forecast and that is why after hours there is a race to dump this stock. Already under 100. How low will it go?
 






anonymous said:
What an earnings call today! The boys can dance around the question but the fact remains...nobody is paying for Skytrofa. The overwhelming majority of the 708 patients are on drug provided by Ascendis. That is why you missed the revenue forecast and that is why after hours there is a race to dump this stock. Already under 100. How low will it go?
Click to expand...
F'ing crooks.....Novo Nordisk throw-aways lose again but line their own pockets with bonus for "superior performance." I should have dumped this stock months ago.
 












This is what happens with terrible leadership. Same thing happened at Radius Health with this leadership team. Shame on the team that hired this group for launch. It was doomed from the start.
 
























Top Bottom
Back
Quote